Scientists create new cell lines from ocular melanoma patients

Mar 11, 2011

Researchers at UCLA's Jules Stein Eye Institute have created new tumor cell lines from fine-needle biopsies of ocular melanoma patients who had undergone treatment but died when their cancer spread aggressively.

These new cell lines will afford scientists valuable insights into how the eye cancer causes rapid metastasis. The findings could lead to new methods for testing drugs for treatment.   

Until now, scientists have had a limited number of models for studying ocular . The cancer does not naturally occur in animals, and commercially available may differ from the original

"Each cell line retained the molecular features found in its original tumor," said principal investigator Dr. Tara McCannel. "That's important, because the more closely a model resembles the actual tumor, the more likely that discoveries made using the model are to be valid."

Ocular melanoma, which forms in the pigmented layers under the retina, is the most common in adults, with approximately 2,000 new cases (seven in 1 million people) diagnosed each year. The cause remains unknown.

Patients whose tumors contain a genetic marker linked to rapid metastasis have at least a 50 percent chance of death within five years, due to swift spreading of the tumor to the liver and other organs. Particularly aggressive cases can result in blindness and death within a year.

Explore further: Researchers find new fertility drug to be more effective than one used for past 40 years

More information: The research appears in the Feb. 25 online edition of the journal Molecular Vision.

add to favorites email to friend print save as pdf

Related Stories

Melanoma uses body's immune system to spread to lungs

Sep 24, 2010

(PhysOrg.com) -- The way melanoma cells use the immune system to spread and develop into lung tumors may lead to a therapy to decrease development of these tumors, according to Penn State researchers.

Recommended for you

Early hormone therapy may be safe for women's hearts

7 hours ago

(HealthDay)—Healthy women at low risk of cardiovascular disease may be able to take hormone replacement therapy soon after menopause for a short time without harming their hearts, according to a new study.

Low yield for repeat colonoscopy in some patients

8 hours ago

(HealthDay)—Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, ...

Cell's recycling center implicated in division decisions

10 hours ago

Most cells do not divide unless there is enough oxygen present to support their offspring, but certain cancer cells and other cell types circumvent this rule. Researchers at The Johns Hopkins University have now identified ...

User comments : 0